Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus
Reports outline human papillomavirus study findings from University of Birmingham
November 19th, 2008
According to a study from Birmingham, the United Kingdom, "We have evaluated a neutralizing antibody assay which uses human papillomavirus (HPV) type 16 (HPV-16) and HPV-18 pseudovirions carrying a secretory alkaline phosphatase reporter gene and which can potentially measure functionally relevant HPV type-specific neutralizing antibodies. The reproducibility of the assay was excellent; for HPV-16, the intra- and interassay kappa values were 0.95 and 0.90, respectively; and for HPV-18, the corresponding values were 0.90 and 0.90." "This assay was used to describe the kinetics of the neutralizing antibody response in a cohort of 42 young women who were recruited soon...
Source: Vaccine Weekly (2008-11-19)
|
